DB06098InvestigationalSmall molecule
PRLX 93936 is selectively toxic to cancer cells.
- Mechanism
- Curator reviewed
PRLX 93936 appears to inhibit mitochondrial outer membrane protein VDACs (voltage-dependent anion channels) 2 and 3, resulting in an oxidative, non-apoptotic cell death.
- Primary indication
- Investigated for use/treatment in solid tumors.Curator reviewed
- Code names
- PRLX 93936
Resolves to
Targets
What you can answer from here — as of April 02, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with PRLX 93936, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account